Health Dictionary Find a Doctor

Allergic conjunctivitis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]

Overview

Allergic conjunctivitis is usually a non-progressive condition with a favorable prognosis, and rare but serious complications. Most symptoms are self-limiting, while in some subtypes, a temporal association can be found with the age group and specific triggers. Complications include infections, scarring and can also damage the cornea and eyelids. Long-term prognosis is influenced by the recurrence of the attacks and side-effects of treatment.

Natural History

Symptoms are often neglected, and resolve in many patients without medical care.

Complete resolution without the return of symptoms after adolescence is observed in a majority of patients.

Uncommon before adolescence and peaks from 30 to 50 years of age. Most cases coexist with atopic dermatitis.

  • A temporal relationship with contact lens use may explain the predominance of this variety in teens and young adults.
  • It manifests usually after one to two years of wearing soft contact lenses but varies widely with other ocular foreign bodies[1].

Complications

In most cases, allergic conjunctivitis is a benign condition. Complications although rare,can be serious and include:

Prognosis[2]

  • PAC and SAC demonstrate favorable long-term outcomes but, significant eye discomfort and poor ocular cosmesis may persist as long-term sequelae in many people.
  • Recurrences result in conjunctivochalasis, which is a result of ongoing limba conjunctival chemosis.
  • The medications may cause adverse reactions like cataracts.

References

  1. Sen E, Celik S, Inanc M, Elgin U, Ozyurt B, Yılmazbas P (2018). “Seasonal distribution of ocular conditions treated at the emergency room: a 1-year prospective study”. Arq Bras Oftalmol. 81 (2): 116–119. doi:10.5935/0004-2749.20180026. PMID 29846426.
  2. 2.0 2.1 2.2 Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H; et al. (2017). “Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis”. Allergy. 72 (11): 1597–1631. doi:10.1111/all.13201. PMID 28493631.

Template:WH Template:WS

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH